Structures by: Wong E. H.
Total: 10
C23H36ClCuN5O8
C23H36ClCuN5O8
Journal of medicinal chemistry (2007) 50, 10 2527-2535
a=21.134(4)Å b=10.7258(16)Å c=23.111(4)Å
α=90.00° β=90.00° γ=90.00°
C19H37ClCuN4O9
C19H37ClCuN4O9
Dalton transactions (Cambridge, England : 2003) (2007) 21 2150-2162
a=27.6657(19)Å b=7.9539(6)Å c=10.7296(7)Å
α=90.00° β=90.00° γ=90.00°
C18H38Cl2CuN4O14
C18H38Cl2CuN4O14
Dalton transactions (Cambridge, England : 2003) (2007) 21 2150-2162
a=8.7623(5)Å b=17.9633(10)Å c=17.2184(10)Å
α=90.00° β=93.2180(10)° γ=90.00°
C37H70Cl3Cu2N8Na3O21
C37H70Cl3Cu2N8Na3O21
Dalton transactions (Cambridge, England : 2003) (2007) 21 2150-2162
a=15.6342(17)Å b=34.587(4)Å c=9.4238(10)Å
α=90.00° β=90.00° γ=90.00°
C16H28N4O4Cu,ClO4,Na,3(H2O)
C16H28N4O4Cu,ClO4,Na,3(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 21 2150-2162
a=8.0242(5)Å b=9.3141(6)Å c=15.3597(10)Å
α=96.6070(10)° β=97.3590(10)° γ=92.5420(10)°
C15H40CuN4O10.5P
C15H40CuN4O10.5P
Dalton transactions (Cambridge, England : 2003) (2012) 41, 7 1938-1950
a=10.1989(19)Å b=35.067(7)Å c=12.943(3)Å
α=90.00° β=90.00° γ=90.00°
C14H33N4O6P2,4(H2O),Cl
C14H33N4O6P2,4(H2O),Cl
Dalton Transactions (2010) 39, 7 1699-1701
a=11.5219(16)Å b=11.7468(16)Å c=9.6554(13)Å
α=90.00° β=115.254(3)° γ=90.00°
C14H38Cl0.5CuN4Na0.5O10P2
C14H38Cl0.5CuN4Na0.5O10P2
Dalton Transactions (2010) 39, 7 1699-1701
a=9.5428(5)Å b=15.5173(7)Å c=16.9240(10)Å
α=80.039(4)° β=81.081(4)° γ=89.874(3)°
C32H56Cr2N4O12P4
C32H56Cr2N4O12P4
Acta Crystallographica Section C (1993) 49, 12 2081-2083
a=11.634(2)Å b=12.1720(10)Å c=10.056(2)Å
α=114.099(9)° β=115.050(10)° γ=92.810(10)°
C139.25H130.5Ag3CsN8.75O20.75P6Sn2
C139.25H130.5Ag3CsN8.75O20.75P6Sn2
Inorganic Chemistry (2001) 40, 4504-4506
a=23.7157(3)Å b=23.7157(3)Å c=88.5147(5)Å
α=90.00° β=90.00° γ=120.00°